# Study of High Dose Cyclophosphamide in Patients With Severe Aplastic Anemia and Paroxysmal Nocturnal Hemoglobinuria

> **NCT00004464** · PHASE2 · COMPLETED · sponsor: **Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins** · enrollment: 69 (actual)

## Conditions studied

- Aplastic Anemia
- Paroxysmal Hemoglobinuria, Nocturnal

## Interventions

- **DRUG:** cyclophosphamide
- **DRUG:** filgrastim

## Key facts

- **NCT ID:** NCT00004464
- **Lead sponsor:** Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1996-02
- **Primary completion:** 2007-03-01
- **Final completion:** 2008-11-11
- **Target enrollment:** 69 (ACTUAL)
- **Last updated:** 2019-01-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00004464

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00004464, "Study of High Dose Cyclophosphamide in Patients With Severe Aplastic Anemia and Paroxysmal Nocturnal Hemoglobinuria". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00004464. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*